Healthcare Sector

PFE

Market Tracker

$24.97
-1.05
(-4.04%)
1:39 pm
Next Earnings: (est.) 08/01/23 12:00 am
  • PFE (Selected)

    Pfizer Inc.
  • PFEB

    Innovator S&P 500 Power Buffer ETF - February

PFE Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

PFE Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

PFE Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

PFE Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

PFE Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

PFE Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
02/21/2025 PUT $30.00 15,000 +15,000
02/21/2025 CALL $30.00 15,000 +15,000
01/15/2027 CALL $27.00 12,358 +8,507 +220.90%
11/22/2024 PUT $26.00 47,720 +7,866 +19.74%
11/15/2024 PUT $26.50 12,775 +5,838 +84.16%
12/06/2024 PUT $25.00 4,501 +4,082 +974.22%
11/15/2024 PUT $27.50 1,644 -981 -37.37%
11/22/2024 PUT $28.00 442 -1,692 -79.29%
12/18/2026 PUT $42.00 3,793 -2,000 -34.52%
11/15/2024 PUT $27.00 10,210 -2,997 -22.69%
01/17/2025 PUT $30.00 25,635 -3,919 -13.26%
11/15/2024 PUT $28.00 5,371 -5,474 -50.47%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

PFE Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 3.02% 170.64M 6.14B
Vanguard 500 Index Fund 2.30% 129.76M 4.67B
Washington Mutual Investors Fund 1.42% 80.41M 2.89B
Fidelity 500 Index Fund 1.09% 61.54M 2.21B
SPDR S&P 500 ETF Trust 1.08% 60.77M 2.19B
American Balanced Fund 1.00% 56.61M 2.04B
Income Fund of America Inc 0.93% 52.68M 1.9B
iShares Core S&P 500 ETF 0.89% 50.1M 1.8B
Vanguard Index-Value Index Fund 0.86% 48.51M 1.75B
Vanguard Specialized-Health Care Fund 0.86% 48.32M 1.74B

PFE News

  • Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences

    11/12 02:00 am

    GlobeNewswire Inc.

    Read more
  • Valneva fera des présentations et rencontrera les investisseurs lors de conférences aux États-Unis et en Europe

    11/12 02:00 am

    GlobeNewswire Inc.

    Read more
  • Needle Free Injectors Market Is Expected To Reach a Revenue Of USD 2,980.9 Million By 2033, At 8.1% CAGR: Dimension Market Research

    11/11 12:59 pm

    GlobeNewswire Inc.

    Read more
  • 3 Spectacular High-Yield Dividend Stocks to Buy in November

    11/10 10:30 am

    The Motley Fool

    Read more
  • 2 Magnificent S&P 500 Dividend Stocks Down Year to Date to Buy and Hold Forever

    11/09 12:21 pm

    The Motley Fool

    Read more
  • 2 Magnificent Stocks to Buy That Are Near 52-Week Lows

    11/05 10:45 am

    The Motley Fool

    Read more
  • 1 Green Flag That's Also a Red Flag for Pfizer Stock

    11/05 07:30 am

    The Motley Fool

    Read more
  • Prediabetes Market to hit USD 360.6 million by 2032, says Global Market Insights Inc.

    11/05 07:00 am

    GlobeNewswire Inc.

    Read more
  • 2 Sensational Growth Stocks to Buy at a Discount

    11/03 12:30 pm

    The Motley Fool

    Read more
  • 3 Potential Catalysts That Could Lift Pfizer Stock Before 2025

    11/03 09:33 am

    The Motley Fool

    Read more
  • 3 Factors That Make Pfizer's Ultra-High-Yield Dividend Safer Than You Might Think

    10/31 05:41 am

    The Motley Fool

    Read more
  • Is Eli Lilly Stock a Buy?

    10/30 04:40 am

    The Motley Fool

    Read more
  • Why Pfizer Stock Tumbled on Tuesday

    10/29 07:06 pm

    The Motley Fool

    Read more
  • Global Lung Cancer Therapeutics Market Set to Reach USD 48,725.9 Million by 2026 with an Impressive CAGR of 13.4% growth over the forecast period 2022 to 2032 | FMI

    10/27 08:30 pm

    GlobeNewswire Inc.

    Read more
  • 3 Magnificent S&P 500 Dividend Stocks Down 43%, 20%, and 53% to Buy and Hold Forever

    10/26 06:48 pm

    The Motley Fool

    Read more
  • 1 High-Yield Dividend Growth ETF to Buy With $30 and Hold Forever

    10/26 05:32 am

    The Motley Fool

    Read more
  • Biliary Tract Cancer Market Research Report 2024-2030 with Analyst Recommendations - Develop Comprehensive Care Protocols & Improve Access to Treatments

    10/25 10:56 am

    GlobeNewswire Inc.

    Read more
  • 3 Sweet Dividend Stocks to Treat Your Portfolio With This Halloween

    10/25 04:40 am

    The Motley Fool

    Read more
  • CDC And Prevention Advisory Panel Backs Expanded Use Of Pfizer And Merck's Pneumococcal Vaccines

    10/24 02:46 pm

    Benzinga

    Read more
  • 5 High-Yield Dividend Stocks to Buy Without Hesitation

    10/24 07:45 am

    The Motley Fool

    Read more
  • FDA Approves Pfizer's Respiratory Syncytial Virus Vaccine Abrysvo For Adults Below 60 Years

    10/23 11:31 am

    Benzinga

    Read more
  • This Vaccine Stock Just Dropped by 20%: Should You Buy the Dip?

    10/21 07:45 am

    The Motley Fool

    Read more
  • 1 Ultra-High-Yield Healthcare Stock to Buy Hand Over Fist and 1 to Avoid

    10/21 05:49 am

    The Motley Fool

    Read more
  • 3 Bargain Stocks to Buy in a Market That's Priced for Perfection

    10/19 07:30 am

    The Motley Fool

    Read more
  • Guggenheim's Longstanding Pfizer Ties Tested Amid Starboard Battle

    10/16 08:19 am

    Benzinga

    Read more
  • Saudi Arabia Generic Pharmaceutical Products Market Report 2024-2031, Featuring Profiles of Key Players - Jamjoom Pharma, Pfizer, Hikma Pharma, Fresenius, Novartis & More

    10/16 04:55 am

    GlobeNewswire Inc.

    Read more
  • Prostate Cancer Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 150+ Companies Working in the Domain

    10/15 01:00 pm

    GlobeNewswire Inc.

    Read more
  • 2 Ultra-High-Yield Dividend Stocks With Total Return Potential of Up to 92% in 12 Months, According to Select Wall Street Analysts

    10/15 04:41 am

    The Motley Fool

    Read more
  • These 3 Stocks Just Spiked—Buy the Rally or Sell the News?

    10/14 02:46 pm

    Benzinga

    Read more
  • Hemophilia Markets Poised for Evolution as Competitive Dynamics between Hemlibra (Roche/Genentech) and Altuviiio (Sanofi) Intensify and Hympavzi (Pfizer) Receives Approval, According to Spherix Global Insights

    10/14 12:33 pm

    GlobeNewswire Inc.

    Read more
  • mRNA Cancer Vaccines and Therapeutics Research Report 2024 with Long-term Forecasts to 2028 and 2033: Personalized Medicine and Multivalent mRNA Vaccines Lead the Way

    10/14 11:48 am

    GlobeNewswire Inc.

    Read more
  • Biopharmaceuticals Contract Manufacturing Industry Research 2024-2030: Biopharma Giants Increasingly Outsource to Streamline Drug Developments

    10/14 10:58 am

    GlobeNewswire Inc.

    Read more
  • Chemotherapy Drugs Market Report 2024: Essential Growth Dynamics and Advancements to 2030

    10/14 10:54 am

    GlobeNewswire Inc.

    Read more
  • FDA Approves Pfizer's Second Hemophilia Drug With Six Months

    10/14 07:35 am

    Benzinga

    Read more
  • 2 Incredibly Cheap Big Pharma Stocks to Buy Now

    10/12 06:10 am

    The Motley Fool

    Read more
  • 3 Reliable Dividend Stocks With Yields Above 5% That You Can Buy With Less Than $100 Right Now

    10/12 05:26 am

    The Motley Fool

    Read more
  • Cancer Vaccines Market Forecasts from 2024 to 2029: Lung and Breast Cancer Remain Key Targets, FDA Approvals for HPV and HBV Vaccines Boost Expansion

    10/11 06:49 am

    GlobeNewswire Inc.

    Read more
  • Nasal Drug Delivery Technology Industry Analysis and Opportunity Forecast, 2030 - Strategic Profiles of 47 Key Players in the Projected $125 Billion Market - 3M, AstraZeneca, Johnson & Johnson, Pfizer & More

    10/11 04:46 am

    GlobeNewswire Inc.

    Read more
  • Why Pfizer Stock Tumbled by Nearly 3% on Thursday

    10/10 05:51 pm

    The Motley Fool

    Read more
  • Global Antiemetics Drugs Market to Exhibit Growth at a CAGR of ~6% by 2030 | DelveInsight

    10/10 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers fourth milestone payment for this region to Basilea this year

    10/10 01:15 am

    GlobeNewswire Inc.

    Read more
  • Starke Cresemba® (Isavuconazol)-Umsätze in Asien-Pazifik und China lösen vierte Meilensteinzahlung für diese Region in diesem Jahr an Basilea aus

    10/10 01:15 am

    GlobeNewswire Inc.

    Read more
  • S&P 500 Hits New All-Time High Ahead Of Fed Minutes As Lower Oil Prices Offer Relief: What's Driving Markets Wednesday?

    10/09 12:03 pm

    Benzinga

    Read more
  • Germany Pharmaceuticals Market Report 2024-2028: Consolidation through Mergers and Acquisitions Catalyzing Growth

    10/09 06:43 am

    GlobeNewswire Inc.

    Read more
  • As a Billionaire Activist Takes a Stake, Is Now the Time to Buy Pfizer Stock?

    10/09 04:55 am

    The Motley Fool

    Read more
  • 4 Reasons Pfizer Could Be a Value Play You Can't Miss

    10/08 07:52 am

    Investing.com

    Read more
  • Why Pfizer Stock Popped on Monday

    10/07 12:18 pm

    The Motley Fool

    Read more
  • Wall Street Set To Start New Week Sharply Lower As Traders Brace For Key Economic Data And Fed Minutes: Why Strategist Sees Market Consolidating In Near Term

    10/07 06:41 am

    Benzinga

    Read more
  • Amid Pfizer's Struggles With Declining Demand For COVID-19 Treatments, Activist Investor Starboard Value Invests $1B In Pharma Giant: Report

    10/06 09:49 pm

    Benzinga

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: